[1] Luedde T,Schwabe RF.NF-kappaB in the liver-linking injury,fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol,2011,8(2):108-118. [2] Lee YA,Wallace MC,Friedman SL.Pathobiology of liver fibrosis:a translational success story. Gut,2015,64(5):830-841. [3] Bartke N,Hannun YA. Bioactive sphingolipids:metabolism and function. J Lipid Res,2009,50 Suppl:S91-96. [4] Lingwood D,Simons K.Lipid rafts as a membrane-organizing principle. Science,2010,327(5961):46-50. [5] Mari M,Fernandez-Checa JC.Sphingolipid signalling and liver diseases. Liver Int,2007,27(4):440-450. [6] Nojima H,Freeman CM,Gulbins E,et al.Sphingolipids in liver injury,repair and regeneration. Biol Chem,2015,396(6-7):633-643. [7] Nowatari T,Murata S,Nakayama K,et al.Sphingosine 1-phosphate has anti-apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human. Hepatol Res,2015,45(11):1136-1145. [8] Morales A,Lee H,Goni FM,et al.Sphingolipids and cell death. Apoptosis,2007,12(5):923-939. [9] Li JF,Qu F,Zheng SJ,et al.Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level. PLoS One,2014,9(4):e95095. [10] Li JF,Qu F,Zheng SJ,et al.Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection. Eur J Clin Microbiol Infect Dis,2014,33(10):1725-1732. [11] Li JF,Qu F,Zheng SJ,et al.Plasma sphingolipids:potential biomarkers for severe hepatic fibrosis in chronic hepatitis C. Mol Med Rep,2015,12(1):323-330. [12] Zheng SJ,Qu F,Li JF,et al.Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. Int J Infect Dis,2015,33:149-155. [13] Zhang JY,Qu F,Li JF,et al.Up-regulation of plasma hexosylceramide(d18:1/18:1) contributes to genotype 2 virus replication in chronic hepatitis C:A 20-year cohort study. Medicine (Baltimore),2016,95(23):e3773. [14] Liu YY,Hill RA,Li YT.Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv Cancer Res,2013,117:59-89. [15] Haynes CA,Allegood JC,Park H,et al.Sphingolipidomics:methods for the comprehensive analysis of sphingolipids. J Chromatogr B Analyt Technol Biomed Life Sci,2009,877(26):2696-2708. [16] Verheij M,Bose R,Lin XH,et al.Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature,1996,380(6569):75-79. [17] Brooks C,Dong Z. Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins:a key in Bak? Cell Cycle,2007,6(24):3043-3047.、 [18] Li P,Nijhawan D,Budihardjo I,et al.Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell,1997,91(4):479-489. [19] Pan G,O'Rourke K,Dixit V M. Caspase-9,Bcl-XL,and Apaf-1 form a ternary complex. J Biol Chem,1998,273(10):5841-5845. [20] 宋金玥,任锋,张桓虎. 坏死性凋亡在肝炎以及其他肝病发病中的作用研究进展. 实用肝脏病杂志,2016,19(5):616-619. |